FAST NEWS: Simcere Pharma Surges After Applying for New Drug Clinical Trials
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) said on Thursday its self-developed anti-tumor drug candidates SIM0237 and SIM0348 were accepted by the Center For Drug Evaluation of China’s National Medical…
FAST NEWS: Investment Loss Undermines Simcere Pharma’s Profit
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) on Wednesday reported its revenue grew 27.3% to 2.7 billion yuan ($389 million) in the first half of the year, while its net profit…
FAST NEWS: Simcere Pharma Says 2021 Profit Doubled, But Shares Fall
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) released a positive profit alert on Monday evening, estimating its net profit last year was in the range of 1.48 billion ($233 million)…
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK -
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
- InSilico seeks IPO boost to get AI drugs over the line
-
Everest reaches new heights on growing drug sales
1952.HK
-
HBM gets health boost from drug licensing deals
2142.HK
